What is tachycardia-induced cardiomyopathy and its management?

• A. Prolonged tachycardia leading to LV dysfunction; management includes rate/rhythm control and treating HF.
• B. It is a short-term condition that resolves without therapy.
• C. It is unrelated to LV function.
• D. Managed with diuretics alone.

Answer: (A)

Tachycardia-induced cardiomyopathy occurs when a persistent fast heart rate from a tachyarrhythmia drives LV systolic dysfunction. The heart stays overworked, calcium handling and myocyte performance worsen, and the ventricle remodels, leading to reduced ejection fraction. Importantly, this is often reversible: once the tachycardia is controlled and the heart rate stays in a normal range, LV function can recover over weeks to months.

Management focuses on eliminating or minimizing the tachycardia while supporting the failing heart. This means rate control or rhythm control to suppress the incessant fast rhythm (using beta-blockers, appropriate antiarrhythmics, electrical cardioversion, or catheter ablation as needed). At the same time, treat heart failure with guideline-directed medical therapy—neb, such as an ACE inhibitor or ARNI, beta-blocker, mineralocorticoid receptor antagonist, and diuretics for symptoms as indicated. Address the underlying rhythm disorder (for example, anticoagulation if atrial fibrillation with risk factors), and monitor LV function to confirm recovery.

Diuretics alone won’t fix the root problem, and the condition is not simply a short-term issue that resolves without intervention, nor is it unrelated to LV function. The key concept is that controlling the tachycardia and applying heart failure therapy can restore LV function.